pfizer Pfizer and BioNTech Request Emergency FDA Authorization for 95% Effective COVID-19 Vaccine Pfizer and BioNTech officially request emergency use authorization from the FDA for their highly effective COVID-19 vaccine. The companies plan to distribute millions of doses globally within hours of receiving approval.
pfizer Pfizer Seeks Emergency Approval for Highly Effective COVID-19 Vaccine Pfizer officially asks U.S. regulators for emergency use authorization of its COVID-19 vaccine, which shows 95% effectiveness. Limited vaccine supplies could reach Americans by next month.
pfizer Pfizer and BioNTech Submit Covid-19 Vaccine for FDA Emergency Authorization Pfizer and BioNTech officially ask the FDA to grant emergency use authorization for their coronavirus vaccine. The request brings the world one step closer to deploying a highly effective shot.
pfizer Pfizer Seeks Emergency FDA Approval for Highly Effective COVID-19 Vaccine Pfizer and BioNTech officially request emergency use authorization from the FDA for their COVID-19 vaccine after clinical trials show 95% effectiveness. The company states it is ready to begin distributing the vaccine within hours of receiving federal approval.
pfizer Pfizer Seeks Emergency FDA Approval for Highly Effective COVID-19 Vaccine Pfizer and BioNTech officially apply for FDA emergency use authorization for their coronavirus vaccine, which shows 95% efficacy in final trials. If approved, the first doses could reach high-risk Americans by mid-December.
moderna Moderna Reports 94.5% Efficacy for Its Coronavirus Vaccine Moderna announces that its experimental coronavirus vaccine demonstrates a 94.5% effectiveness rate in preventing COVID-19. The results closely follow similar positive data released by Pfizer last week.
moderna Moderna Covid-19 Vaccine Shows 94.5% Efficacy in Late-Stage Trials Moderna reports that its two-dose coronavirus vaccine demonstrates a 94.5% effectiveness rate in preventing Covid-19. The promising results follow a similar announcement from Pfizer as regulators prepare for fast-tracked emergency approvals.
stock market Dow Jumps Over 1,500 Points as Pfizer Vaccine News Lifts Markets US stock markets surge after Pfizer announces promising early results for its Covid-19 vaccine, adding to optimism following the presidential election.
pfizer Pfizer Reports Over 90% Efficacy for Experimental COVID-19 Vaccine Pfizer announces that its experimental COVID-19 vaccine demonstrates more than 90% effectiveness in preventing infection based on early trial data.
stock market Markets Surge as Pfizer Reports Highly Effective COVID-19 Vaccine Global stock markets experience massive gains after Pfizer announces its coronavirus vaccine shows more than 90% effectiveness. The historic rally lifts industries hit hardest by the pandemic while dropping tech stocks.
pfizer Pfizer Covid-19 Vaccine Shows Over 90% Effectiveness in Clinical Trials Pfizer and BioNTech report their coronavirus vaccine is more than 90% effective at preventing infection, far exceeding initial expert expectations. The breakthrough sparks a massive global market rally and offers renewed hope for ending the pandemic.
pfizer Pfizer and BioNTech Report 90 Percent Efficacy for Experimental COVID-19 Vaccine Pfizer and BioNTech announce that their experimental coronavirus vaccine shows more than 90 percent effectiveness in preventing COVID-19 during a large phase III trial. The genetically engineered vaccine uses an innovative RNA approach that allows for rapid manufacturing.
dow jones Dow Jones Ousts Exxon Mobil After 92 Years in Major Index Shake-Up The Dow Jones Industrial Average removes legacy giants Exxon Mobil, Pfizer, and Raytheon, replacing them with Salesforce, Amgen, and Honeywell to offset Apple's upcoming stock split.
salesforce Salesforce Joins Dow Jones as Index Drops ExxonMobil, Pfizer, and Raytheon The Dow Jones Industrial Average undergoes a major shakeup by adding cloud software giant Salesforce and removing three legacy industrial stocks. This historic shift highlights the growing dominance of the tech sector over traditional oil and pharmaceutical industries.
dow jones Dow Jones Swaps Exxon, Pfizer, and Raytheon for Salesforce, Amgen, and Honeywell The Dow Jones Industrial Average undergoes a major shake-up as Salesforce, Amgen, and Honeywell replace Exxon Mobil, Pfizer, and Raytheon Technologies. This rare three-stock swap offsets the significant drop in technology weighting caused by Apple's upcoming stock split.